Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Patent Publication Number 20180325885

US 20180325885 A1

Patent NumberUS 10555939 B2

Application Number15976808

Filled DateMay 10, 2018

Priority DateMay 19, 2009

Publication DateNov 15, 2018

Original AssigneeBristol Myers Squibb

Current AssigneeCelgene

Inventor/ApplicantsMichael T. Kelly
Anthony J. Tutino

See the invalidated claims, subscribe to our Concierge Program.

View Concierge Program

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.